Danny Bega

1.9k total citations
66 papers, 1.0k citations indexed

About

Danny Bega is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Danny Bega has authored 66 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Neurology, 19 papers in Psychiatry and Mental health and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Danny Bega's work include Parkinson's Disease Mechanisms and Treatments (21 papers), Genetic Neurodegenerative Diseases (17 papers) and Neurological disorders and treatments (15 papers). Danny Bega is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (21 papers), Genetic Neurodegenerative Diseases (17 papers) and Neurological disorders and treatments (15 papers). Danny Bega collaborates with scholars based in United States, United Kingdom and Poland. Danny Bega's co-authors include Cindy Zadikoff, Tanya Simuni, Mitra Afshari, Amy Yang, Roneil G. Malkani, Paulina González-Latapí, Chen Yeh, Hubert H. Fernandez, Robert A. Hauser and Joohi Jimenez‐Shahed and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of Neurology.

In The Last Decade

Danny Bega

58 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danny Bega United States 17 534 293 210 124 108 66 1.0k
Weerasak Muangpaisan Thailand 18 237 0.4× 273 0.9× 67 0.3× 43 0.3× 43 0.4× 69 1.0k
Saturio Vega Spain 17 539 1.0× 394 1.3× 237 1.1× 26 0.2× 18 0.2× 28 1.4k
Jorge J. Llibre‐Guerra United States 13 247 0.5× 168 0.6× 82 0.4× 17 0.1× 23 0.2× 51 834
Paula B. Davis United States 6 89 0.2× 663 2.3× 128 0.6× 110 0.9× 82 0.8× 7 1.3k
Ghorban Taghizadeh Iran 16 192 0.4× 252 0.9× 50 0.2× 170 1.4× 9 0.1× 110 796
Maira Tonidandel Barbosa Brazil 16 240 0.4× 295 1.0× 50 0.2× 29 0.2× 14 0.1× 60 831
Mary A. Coats United States 11 162 0.3× 735 2.5× 87 0.4× 30 0.2× 11 0.1× 13 1.2k
Maya Katz United States 21 746 1.4× 118 0.4× 266 1.3× 22 0.2× 17 0.2× 48 1.4k
Keith Robinson United States 19 259 0.5× 266 0.9× 29 0.1× 162 1.3× 13 0.1× 61 1.2k
Etsuko Oshima Japan 15 102 0.2× 276 0.9× 73 0.3× 13 0.1× 30 0.3× 33 635

Countries citing papers authored by Danny Bega

Since Specialization
Citations

This map shows the geographic impact of Danny Bega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Bega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Bega more than expected).

Fields of papers citing papers by Danny Bega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danny Bega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Bega. The network helps show where Danny Bega may publish in the future.

Co-authorship network of co-authors of Danny Bega

This figure shows the co-authorship network connecting the top 25 collaborators of Danny Bega. A scholar is included among the top collaborators of Danny Bega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danny Bega. Danny Bega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Song, Jing, et al.. (2025). Association between Perceived Dysphagia Symptoms and Swallowing Physiology in Parkinson's Disease. Movement Disorders Clinical Practice. 12(10). 1571–1581.
3.
Bega, Danny, et al.. (2025). New Onset Parkinson’s Disease Psychosis after use of “Horny Goat Weed” Supplement. Parkinsonism & Related Disorders. 134. 107670–107670.
4.
Manoocheri, Kasra, et al.. (2025). New‐Onset Psychosis in a Person with Parkinson's Disease after “Horny Goat Weed” Use. Movement Disorders Clinical Practice. 13(2). 541–543.
5.
Brooker, Sarah M., et al.. (2024). Caffeine Use in Huntington’s Disease: A Single Center Survey. Tremor and Other Hyperkinetic Movements. 14. 52–52.
6.
Rafferty, Miriam, Han Su, Masha Kocherginsky, et al.. (2023). Financial hardship is associated with employment challenges and reduced quality of life in early Parkinson’s disease. Clinical Parkinsonism & Related Disorders. 9. 100225–100225.
7.
Sokol, Leonard L., Jonathan P. Troost, Danny Bega, et al.. (2023). Advance Care Planning and Health-Related Quality of Life in Huntington Disease: Results from a Multicenter National Study. SHILAP Revista de lepidopterología. 4(1). 79–88.
8.
Bega, Danny, et al.. (2021). Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis. npj Parkinson s Disease. 7(1). 43–43. 52 indexed citations
9.
Bega, Danny, et al.. (2021). Weeding through the haze: a survey on cannabis use among people living with Parkinson’s disease in the US. npj Parkinson s Disease. 7(1). 21–21. 21 indexed citations
10.
Cohen‐Zimerman, Shira, et al.. (2019). Suicidal ideation and behavior in Huntington's disease: Systematic review and recommendations. Journal of Affective Disorders. 250. 319–329. 38 indexed citations
11.
Fernandez, Hubert H., David Stamler, Mat D. Davis, et al.. (2019). Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia. Journal of Neurology Neurosurgery & Psychiatry. 90(12). jnnp–2018. 43 indexed citations
12.
Bega, Danny, et al.. (2018). Acupuncture as Adjuvant Therapy for the Management of Cervical Dystonia. Medical Acupuncture. 30(4). 198–203. 5 indexed citations
13.
Jaros, Joanna, et al.. (2017). Paraneoplastic Peripheral Nervous System Manifestations of Renal Cell Carcinoma: A Case Report and Review of the Literature. Case Reports in Neurology. 9(1). 22–30. 8 indexed citations
14.
Bega, Danny, et al.. (2016). Laughter is the best medicine: The Second City® improvisation as an intervention for Parkinson's disease. Parkinsonism & Related Disorders. 34. 62–65. 18 indexed citations
15.
Bega, Danny, Paulina González-Latapí, Cindy Zadikoff, William G. Spies, & Tanya Simuni. (2015). Is There a Role for DAT-SPECT Imaging in a Specialty Movement Disorders Practice?. Neurodegenerative Diseases. 15(2). 81–86. 14 indexed citations
17.
Bega, Danny, Paulina González-Latapí, Cindy Zadikoff, & Tanya Simuni. (2014). A Review of the Clinical Evidence for Complementary and Alternative Therapies in Parkinson’s Disease. Current Treatment Options in Neurology. 16(10). 314–314. 48 indexed citations
18.
Bega, Danny, Sam Wu, Qinglin Pei, Péter Schmidt, & Tanya Simuni. (2014). Recognition and Treatment of Depressive Symptoms in Parkinson's Disease: The NPF Dataset. Journal of Parkinson s Disease. 4(4). 639–643. 12 indexed citations
19.
Bega, Danny, et al.. (2012). Fatal Hyperammonemic Brain Injury from Valproic Acid Exposure. Case Reports in Neurology. 4(3). 224–230. 17 indexed citations
20.
Bega, Danny, et al.. (2008). Diffusion Weighted Imaging in Heroin-associated Spongiform Leukoencephalopathy. Neurocritical Care. 10(3). 352–354. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026